Raja M Flores, MD Email Raja Flores
- PROFESSOR AND SYSTEM CHAIR | Thoracic Surgery
- Thoracic Surgery
- Hospital Affiliations
- Mount Sinai Queens
- Mount Sinai Morningside and Mount Sinai West
- Mount Sinai Beth Israel
- The Mount Sinai Hospital
- Mount Sinai Brooklyn
- 212-241-9466 212-241-9466
Dr. Raja M. Flores is the Chairman for the Department of Thoracic Surgery, Steven and Ann Ames Professor in Thoracic Surgery at The Mount Sinai Medical Center.
Dr. Flores’ is a recognized leader in the field of Thoracic Surgery for his pioneering efforts in the treatment of mesothelioma. He has established VATS lobectomy, a minimally invasive approach using three small incisions, as the gold standard in the surgical treatment of lung cancer. He published two sentinel studies validating its oncological effectiveness by demonstrating equivalent survival and recurrence rates with fewer complications and shorter hospital stays when compared to standard thoracotomy. Dr. Flores implemented the current program for this procedure at Memorial Sloan-Kettering Cancer Center. He was a lead investigator in a multicenter trial of neoadjuvant alimta/cisplatin, extrapleural pneumonectomy, and high-dose radiation which is designed to improve outcomes.
Dr. Flores currently has one of the largest VATS lobectomy experiences in the world. He has published this data and has presented it at numerous national and international meetings.
Dr. Flores’ additional research interests are based on numerous past projects relating to the multimodality management of malignant pleural mesothelioma, as well as innovative surgical techniques in minimally invasive thoracic surgery for lung cancer. He has led a number of major studies, including clinical trials of neoadjuvant gemcitabine and cisplatin followed by extrapleural pneumonectomy and high dose radiation. Presently, he has received a $395,000 subaward grant from the University of Pittsburgh Department of Biomedical Informatics. Dr. Flores represents Mount Sinai Medical Center's efforts and, along with his group, contributes to the National Mesothelioma Virtual Bank which provides a wide array of well-categorized, searchable biospecimens to investigate the disease process of mesothelioma and potential therapeutic targets. Dr. Flores is the Principle Investigator of the Libby Epidemiology Research Program, a $4.8 million RO1 grant funded by the Agency for Toxic Substances and Disease Registry (ATSDR). The major goals of the research are to address questions regarding the health consequences of asbestos exposure (Libby Amphibole).
After earning an undergraduate degree in biochemistry from New York University, Dr. Flores attended the Albert Einstein College of Medicine, receiving his Medical Degree in 1992. He then spent five years at Columbia-Presbyterian Medical Center pursuing his General Surgery Internship and General Surgery Residency. He then completed a Thoracic Oncology Clinical Research Fellowship at Brigham and Women’s Hospital/Dana Faber Cancer Institute/CALGB in Boston, and his Cardiothoracic Surgery Residency at Brigham and Women’s Hospital, Harvard Medical School. He also received a Masters in Biostatistics from Columbia University. Dr. Flores is a member of numerous medical and surgical societies and serves on several editorial boards.
In the News
Dr. Flores discusses mesothelioma in the NY Daily News feature, The Daily Checkup.
American Board of Surgery
- Benign Neoplasm
- Bronchoscopy, Diagnostic
- Cancer Treatment
- Chest Wall Mass
- Esophageal Cancer
- Hiatal Hernia
- Lung Cancer
- Mediastinal Abnormalities
- Pectus Excavatum
- Pleural Mesothelioma
- Pulmonary Lobectomy
- Robot-Assisted Thoracic Procedures
- Upper GI Endoscopy
BA, New York University
MD, Albert Einstein College of Medicine
MS, Columbia University
Columbia-Presbyterian Medical Center
Residency, Cardiothoracic Surgery
Brigham and Women's Hospital, Harvard Medical School
Spanish, Arabic, English
Steven and Ann Ames Professorship in Thoracic Surgery
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Dr.Flores did not report having any of the following types of financial relationships with industry during 2019 and/or 2020: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.